Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Differences in Clinical Manifestations and Hematological and Serological Responses after Experimental Infection with Genetic Variants of Anaplasma phagocytophilum in Sheep

Differences in Clinical Manifestations and Hematological and Serological Responses after... Five-month-old lambs were experimentally infected with two 16S rRNA genetic variants of Anaplasma phagocytophilum , variants 1 (GenBank accession no. M73220 ) and 2 (GenBank accession no. AF336220 ). Additional sequencing of the groESL heat shock operon gene indicated that these variants differ in three nucleotides at positions 782, 824, and 890. The variants were obtained by blood sampling of A . phagocytophilum -infected lambs from one sheep flock in Norway and were stored at -70°C with 10% dimethyl sulfoxide as a cryoprotectant before being inoculated intravenously into susceptible lambs. The infectious blood contained, per ml, approximately 0.5 x 10 6 neutrophils infected with either of the variants. Six weeks after the primary inoculation, the lambs were challenged with the same infectious dose of the heterologous variant. The results of the study indicate a marked difference in clinical manifestation, neutropenia, antibody response, and cross-protection after experimental infection with the two variants of A. phagocytophilum . http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Clinical and Vaccine Immunology American Society For Microbiology

Differences in Clinical Manifestations and Hematological and Serological Responses after Experimental Infection with Genetic Variants of Anaplasma phagocytophilum in Sheep

Differences in Clinical Manifestations and Hematological and Serological Responses after Experimental Infection with Genetic Variants of Anaplasma phagocytophilum in Sheep

Clinical and Vaccine Immunology , Volume 10 (4): 692 – Jul 1, 2003

Abstract

Five-month-old lambs were experimentally infected with two 16S rRNA genetic variants of Anaplasma phagocytophilum , variants 1 (GenBank accession no. M73220 ) and 2 (GenBank accession no. AF336220 ). Additional sequencing of the groESL heat shock operon gene indicated that these variants differ in three nucleotides at positions 782, 824, and 890. The variants were obtained by blood sampling of A . phagocytophilum -infected lambs from one sheep flock in Norway and were stored at -70°C with 10% dimethyl sulfoxide as a cryoprotectant before being inoculated intravenously into susceptible lambs. The infectious blood contained, per ml, approximately 0.5 x 10 6 neutrophils infected with either of the variants. Six weeks after the primary inoculation, the lambs were challenged with the same infectious dose of the heterologous variant. The results of the study indicate a marked difference in clinical manifestation, neutropenia, antibody response, and cross-protection after experimental infection with the two variants of A. phagocytophilum .

Loading next page...
 
/lp/american-society-for-microbiology/differences-in-clinical-manifestations-and-hematological-and-UYv8D0i2TF

References (23)

Publisher
American Society For Microbiology
Copyright
Copyright © 2003 by the American Society For Microbiology.
ISSN
1556-6811
eISSN
1556-6811
DOI
10.1128/CDLI.10.4.692-695.2003
Publisher site
See Article on Publisher Site

Abstract

Five-month-old lambs were experimentally infected with two 16S rRNA genetic variants of Anaplasma phagocytophilum , variants 1 (GenBank accession no. M73220 ) and 2 (GenBank accession no. AF336220 ). Additional sequencing of the groESL heat shock operon gene indicated that these variants differ in three nucleotides at positions 782, 824, and 890. The variants were obtained by blood sampling of A . phagocytophilum -infected lambs from one sheep flock in Norway and were stored at -70°C with 10% dimethyl sulfoxide as a cryoprotectant before being inoculated intravenously into susceptible lambs. The infectious blood contained, per ml, approximately 0.5 x 10 6 neutrophils infected with either of the variants. Six weeks after the primary inoculation, the lambs were challenged with the same infectious dose of the heterologous variant. The results of the study indicate a marked difference in clinical manifestation, neutropenia, antibody response, and cross-protection after experimental infection with the two variants of A. phagocytophilum .

Journal

Clinical and Vaccine ImmunologyAmerican Society For Microbiology

Published: Jul 1, 2003

There are no references for this article.